StockData
PERRIGO Co plc logo

PERRIGO Co plc (PRGO) stock

PRGONYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 27, 2026Last filing: 10-Q on Nov 4, 2026Score 9/3010% below fair value
$15.76−0.42 (-2.60%)

Close on Nov 17, 2026Market cap $2.19BP/E –Yield 7.36%

Perrigo operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Perrigo's operating cash flow for the twelve months ending Jun 27, 2026 was $196.10M, down 46.5% year over year. For fiscal 2025 it was $238.50M, down 34.3% from the year before. Over ten years it grew -9.3% a year on average. The highest annual figure on record is $855.20M in fiscal 2015.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025$238.50M-34.3%
FY2024Dec 31, 2024$362.90M-10.5%
FY2023Dec 31, 2023$405.50M+32.0%
FY2022Dec 31, 2022$307.30M+96.6%
FY2021Dec 31, 2021$156.30M-75.4%
FY2020Dec 31, 2020$636.20M+64.1%
FY2019Dec 31, 2019$387.80M-34.6%
FY2018Dec 31, 2018$593.00M-15.2%
FY2017Dec 31, 2017$698.90M-18.3%
FY2015Jun 27, 2015$855.20M+35.1%
FY2014Jun 28, 2014$633.00M+14.3%
FY2013Jun 29, 2013$553.80M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q2 FY2026CQ2 2026Jun 27, 2026$82.60M+8.8%
Q1 FY2026CQ1 2026Mar 28, 2026-$113.60M–
Q4 FY2025CQ4 2025Dec 31, 2025$175.40M-43.9%
Q3 FY2025CQ3 2025Sep 27, 2025$51.70M+22.5%
Q2 FY2025CQ2 2025Jun 28, 2025$75.90M+698.9%
Q1 FY2025CQ1 2025Mar 29, 2025-$64.50M–
Q4 FY2024CQ4 2024Dec 31, 2024$312.60M+49.8%
Q3 FY2024CQ3 2024Sep 28, 2024$42.20M-66.1%
Q2 FY2024CQ2 2024Jun 29, 2024$9.50M-82.0%
Q1 FY2024CQ1 2024Mar 30, 2024-$1.40M-107.2%
Q4 FY2023CQ4 2023Dec 31, 2023$208.70M+12.3%
Q3 FY2023CQ3 2023Sep 30, 2023$124.50M+110.3%
Q2 FY2023CQ2 2023Jul 1, 2023$52.90M–
Q1 FY2023CQ1 2023Apr 1, 2023$19.40M-75.5%
Q4 FY2022CQ4 2022Dec 31, 2022$185.90M–
Q3 FY2022CQ3 2022Oct 1, 2022$59.20M-82.8%
Q2 FY2022CQ2 2022Jul 2, 2022-$16.90M–
Q1 FY2022CQ1 2022Apr 2, 2022$79.10M+39450.0%
Q4 FY2021CQ4 2021Dec 31, 2021-$105.40M-195.5%
Q3 FY2021CQ3 2021Oct 2, 2021$343.80M+444.8%
Q2 FY2021CQ2 2021Jul 3, 2021-$82.30M-128.3%
Q1 FY2021CQ1 2021Apr 3, 2021$200.00K-99.9%
Q4 FY2020CQ4 2020Dec 31, 2020$110.40M+23.4%
Q3 FY2020CQ3 2020Sep 26, 2020$63.10M-54.9%
Q2 FY2020CQ2 2020Jun 27, 2020$290.90M+356.0%
Q1 FY2020CQ1 2020Mar 28, 2020$171.80M+81.8%
Q4 FY2019CQ4 2019Dec 31, 2019$89.50M-53.9%
Q3 FY2019CQ3 2019Sep 28, 2019$140.00M-2.8%
Q2 FY2019CQ2 2019Jun 29, 2019$63.80M-22.5%
Q1 FY2019CQ1 2019Mar 30, 2019$94.50M-45.2%
Q4 FY2018CQ4 2018Dec 31, 2018$194.30M-10.4%
Q3 FY2018CQ3 2018Sep 29, 2018$144.00M-26.8%
Q2 FY2018CQ2 2018Jun 30, 2018$82.30M-9.4%
Q1 FY2018CQ1 2018Mar 31, 2018$172.40M-11.4%
Q4 FY2017CQ4 2017Dec 31, 2017$216.90M+81.4%
Q3 FY2017CQ3 2017Sep 30, 2017$196.70M+9.2%
Q2 FY2017CQ2 2017Jul 1, 2017$90.80M–
Q1 FY2017CQ1 2017Apr 1, 2017$194.50M–
Q4 FY2015CQ2 2015Jun 27, 2015$119.60M–
Q3 FY2015CQ1 2015Mar 28, 2015$180.20M–

More Perrigo figures

See a number that looks wrong?